chrX_-_151938194
|
4.455
|
NM_005362
|
MAGEA3
|
melanoma antigen family A, 3
|
chrX_+_151867244
|
4.404
|
NM_005363
NM_175868
|
MAGEA2
MAGEA6
|
melanoma antigen family A, 2
melanoma antigen family A, 6
|
chrX_-_151903100
|
4.065
|
NM_001166386
NM_001166387
NM_005367
|
MAGEA12
|
melanoma antigen family A, 12
|
chrX_+_151903218
|
3.091
|
NM_001102576
NM_153478
|
CSAG1
|
chondrosarcoma associated gene 1
|
chrX_-_152486073
|
3.074
|
NM_004988
|
MAGEA1
|
melanoma antigen family A, 1 (directs expression of antigen MZ2-E)
|
chrX_+_151883074
|
2.687
|
NM_005361
NM_175742
NM_175743
|
MAGEA2
|
melanoma antigen family A, 2
|
chr19_-_55658310
|
2.452
|
|
TNNT1
|
troponin T type 1 (skeletal, slow)
|
chr6_+_3000026
|
2.316
|
NM_000904
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
chr11_+_46403279
|
2.315
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
chrX_-_151922329
|
2.272
|
NM_005361
NM_175742
NM_175743
|
MAGEA2
|
melanoma antigen family A, 2
|
chr11_+_46403260
|
2.181
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
chr11_+_46403205
|
2.121
|
NM_002391
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
chr20_-_22564893
|
2.120
|
|
FOXA2
|
forkhead box A2
|
chrX_-_137793826
|
2.067
|
NM_004114
|
FGF13
|
fibroblast growth factor 13
|
chrX_-_137793394
|
1.791
|
|
FGF13
|
fibroblast growth factor 13
|
chr21_-_44495894
|
1.673
|
NM_000071
|
CBS
|
cystathionine-beta-synthase
|
chr11_+_46403302
|
1.670
|
NM_001012333
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
chr19_+_860615
|
1.630
|
|
CFD
|
complement factor D (adipsin)
|
chr19_-_55660557
|
1.591
|
NM_001126132
NM_001126133
NM_003283
|
TNNT1
|
troponin T type 1 (skeletal, slow)
|
chr22_-_22901421
|
1.569
|
NM_206955
NM_206956
NM_006115
NM_206953
NM_206954
|
PRAME
|
preferentially expressed antigen in melanoma
|
chr19_-_18717577
|
1.485
|
|
CRLF1
|
cytokine receptor-like factor 1
|
chr19_-_18717631
|
1.466
|
NM_004750
|
CRLF1
|
cytokine receptor-like factor 1
|
chr20_-_22565050
|
1.373
|
NM_021784
|
FOXA2
|
forkhead box A2
|
chr19_-_18717467
|
1.346
|
|
CRLF1
|
cytokine receptor-like factor 1
|
chr1_-_161193190
|
1.310
|
|
APOA2
|
apolipoprotein A-II
|
chrX_-_39956655
|
1.293
|
NM_001123385
NM_017745
|
BCOR
|
BCL6 corepressor
|
chr2_-_218843541
|
1.242
|
|
TNS1
|
tensin 1
|
chr21_-_28339405
|
1.229
|
NM_007038
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
chrX_-_151286410
|
1.224
|
NM_021049
|
MAGEA5
|
melanoma antigen family A, 5
|
chr3_-_185542807
|
1.173
|
NM_001007225
NM_006548
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
chrX_+_152907892
|
1.125
|
NM_001395
|
DUSP9
|
dual specificity phosphatase 9
|
chr12_-_54694717
|
1.118
|
NM_001136023
|
NFE2
|
nuclear factor (erythroid-derived 2), 45kDa
|
chr21_-_44496423
|
1.104
|
NM_001178008
NM_001178009
|
CBS
|
cystathionine-beta-synthase
|
chrX_-_148669108
|
1.079
|
NM_005365
NM_001080790
|
MAGEA9
MAGEA9B
|
melanoma antigen family A, 9
melanoma antigen family A, 9B
|
chr5_+_176513819
|
1.052
|
NM_002011
NM_213647
|
FGFR4
|
fibroblast growth factor receptor 4
|
chr7_-_150675236
|
1.051
|
NM_000238
NM_172056
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2
|
chrX_+_148863592
|
1.041
|
NM_005365
NM_001080790
|
MAGEA9
MAGEA9B
|
melanoma antigen family A, 9
melanoma antigen family A, 9B
|
chrX_-_153881757
|
1.038
|
NM_020994
NM_172377
|
CTAG2
|
cancer/testis antigen 2
|
chrX_+_152908819
|
1.030
|
|
DUSP9
|
dual specificity phosphatase 9
|
chr16_-_28608367
|
1.028
|
NM_001054
|
SULT1A2
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
|
chr16_+_85645014
|
1.003
|
NM_001134473
|
KIAA0182
|
KIAA0182
|
chr10_+_5454516
|
0.997
|
NM_001047160
|
NET1
|
neuroepithelial cell transforming 1
|
chr12_-_54694647
|
0.996
|
|
NFE2
|
nuclear factor (erythroid-derived 2), 45kDa
|
chr11_-_2158510
|
0.995
|
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
chr1_-_1293907
|
0.990
|
NM_032348
|
MXRA8
|
matrix-remodelling associated 8
|
chr6_+_32121775
|
0.963
|
NM_001204103
NM_005155
|
PPT2-EGFL8
PPT2
|
PPT2-EGFL8 readthrough
palmitoyl-protein thioesterase 2
|
chr16_-_28621279
|
0.933
|
NM_001055
NM_177529
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
chr2_-_220436267
|
0.931
|
NM_001173408
NM_001173431
NM_015311
|
OBSL1
|
obscurin-like 1
|
chr12_+_57849086
|
0.931
|
NM_031479
|
INHBE
|
inhibin, beta E
|
chr16_+_30210548
|
0.926
|
NM_001017390
NM_177552
|
SULT1A4
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
|
chr2_+_8822112
|
0.910
|
NM_002166
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
chr10_+_114709963
|
0.905
|
NM_001146274
NM_001146283
NM_001146284
NM_001146285
NM_001146286
NM_001198525
NM_001198526
NM_001198527
NM_001198528
NM_001198529
NM_001198530
NM_001198531
NM_030756
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
chr19_-_18548971
|
0.889
|
NM_001170938
NM_016368
|
ISYNA1
|
inositol-3-phosphate synthase 1
|
chr19_-_18548788
|
0.887
|
NM_001170939
|
ISYNA1
|
inositol-3-phosphate synthase 1
|
chr7_+_94023872
|
0.881
|
NM_000089
|
COL1A2
|
collagen, type I, alpha 2
|
chr18_+_33767420
|
0.877
|
NM_017947
|
MOCOS
|
molybdenum cofactor sulfurase
|
chr20_+_31350387
|
0.851
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
chr2_-_200322699
|
0.849
|
NM_001172509
|
SATB2
|
SATB homeobox 2
|
chr2_-_128432642
|
0.843
|
NM_001136037
NM_001161403
|
LIMS2
|
LIM and senescent cell antigen-like domains 2
|
chr3_-_185542744
|
0.837
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
chrX_-_11284094
|
0.829
|
NM_013423
|
ARHGAP6
|
Rho GTPase activating protein 6
|
chr1_-_21978287
|
0.818
|
NM_001145658
|
RAP1GAP
|
RAP1 GTPase activating protein
|
chr7_-_143599163
|
0.816
|
NM_014719
NM_001206938
|
FAM115A
|
family with sequence similarity 115, member A
|
chr20_+_34742656
|
0.813
|
NM_012156
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1
|
chrX_+_153813417
|
0.813
|
NM_001327
NM_139250
|
CTAG1B
CTAG1A
|
cancer/testis antigen 1B
cancer/testis antigen 1A
|
chr17_-_46703613
|
0.800
|
NM_024017
|
HOXB9
|
homeobox B9
|
chr21_+_47649066
|
0.799
|
|
MCM3AP-AS1
|
MCM3AP antisense RNA 1 (non-protein coding)
|
chr10_-_95360959
|
0.792
|
NM_006744
|
RBP4
|
retinol binding protein 4, plasma
|
chr17_+_79989485
|
0.787
|
NM_005052
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
chr1_+_21835915
|
0.780
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
chr5_-_134369841
|
0.779
|
NM_002653
|
PITX1
|
paired-like homeodomain 1
|
chr9_+_71320105
|
0.773
|
NM_003558
|
PIP5K1B
|
phosphatidylinositol-4-phosphate 5-kinase, type I, beta
|
chr11_-_75062650
|
0.765
|
NM_004041
NM_020251
|
ARRB1
|
arrestin, beta 1
|
chr14_-_21994342
|
0.749
|
|
SALL2
|
sal-like 2 (Drosophila)
|
chr7_+_73868111
|
0.747
|
NM_001199207
NM_005685
NM_016328
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
chr7_+_73868236
|
0.743
|
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
chr7_-_92465876
|
0.741
|
|
CDK6
|
cyclin-dependent kinase 6
|
chr7_-_100239136
|
0.738
|
NM_003227
|
TFR2
|
transferrin receptor 2
|
chr5_-_172756505
|
0.710
|
NM_003714
|
STC2
|
stanniocalcin 2
|
chr6_+_20404033
|
0.695
|
NM_001243076
|
E2F3
|
E2F transcription factor 3
|
chr6_-_6320897
|
0.687
|
NM_000129
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
chr16_+_29471206
|
0.684
|
NM_001017390
NM_177552
|
SULT1A4
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
|
chr2_+_46926049
|
0.683
|
NM_014011
|
SOCS5
|
suppressor of cytokine signaling 5
|
chr1_-_150947456
|
0.677
|
NM_022075
NM_181746
|
CERS2
|
ceramide synthase 2
|
chr17_-_76124791
|
0.676
|
NM_001127198
|
TMC6
|
transmembrane channel-like 6
|
chr6_-_46459010
|
0.674
|
NM_001251974
|
RCAN2
|
regulator of calcineurin 2
|
chr19_+_925984
|
0.674
|
NM_005224
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like)
|
chrY_+_15016775
|
0.674
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked
|
chr10_-_75415748
|
0.668
|
NM_001114133
|
SYNPO2L
|
synaptopodin 2-like
|
chr7_+_73868397
|
0.667
|
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
chrY_+_15016698
|
0.665
|
NM_004660
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked
|
chr15_+_85291802
|
0.660
|
NM_014630
|
ZNF592
|
zinc finger protein 592
|
chr20_-_1165116
|
0.656
|
NM_018354
|
TMEM74B
|
transmembrane protein 74B
|
chr19_+_708766
|
0.653
|
NM_001040134
NM_002579
|
PALM
|
paralemmin
|
chr3_-_13008959
|
0.653
|
NM_014869
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
chr3_+_52009036
|
0.653
|
NM_015407
|
ABHD14A-ACY1
ABHD14A
|
ABHD14A-ACY1 readthrough (non-protein coding)
abhydrolase domain containing 14A
|
chrX_+_30233674
|
0.652
|
NM_002364
|
MAGEB2
|
melanoma antigen family B, 2
|
chr20_-_47804675
|
0.649
|
|
STAU1
|
staufen, RNA binding protein, homolog 1 (Drosophila)
|
chr14_-_21493858
|
0.645
|
|
NDRG2
|
NDRG family member 2
|
chr2_-_227664330
|
0.644
|
|
IRS1
|
insulin receptor substrate 1
|
chr6_-_6320875
|
0.641
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
chr1_-_150947292
|
0.641
|
|
CERS2
|
ceramide synthase 2
|
chr14_-_65346554
|
0.634
|
|
SPTB
|
spectrin, beta, erythrocytic
|
chr3_+_12329332
|
0.626
|
NM_005037
NM_138712
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
chr11_-_414975
|
0.625
|
NM_001135054
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
|
chr11_-_85780105
|
0.615
|
NM_001008660
NM_001206946
NM_007166
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
chr4_-_109089444
|
0.609
|
NM_001130713
NM_001130714
NM_016269
|
LEF1
|
lymphoid enhancer-binding factor 1
|
chr1_-_161193375
|
0.609
|
NM_001643
|
APOA2
|
apolipoprotein A-II
|
chr1_-_38471170
|
0.604
|
NM_001243878
NM_004468
|
FHL3
|
four and a half LIM domains 3
|
chr11_-_34379526
|
0.601
|
NM_145804
|
ABTB2
|
ankyrin repeat and BTB (POZ) domain containing 2
|
chr1_-_150947154
|
0.600
|
|
CERS2
|
ceramide synthase 2
|
chr10_-_735522
|
0.597
|
NM_014974
|
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila)
|
chr19_+_52800424
|
0.597
|
NM_144684
|
ZNF480
|
zinc finger protein 480
|
chrX_-_48693934
|
0.594
|
NM_013271
|
PCSK1N
|
proprotein convertase subtilisin/kexin type 1 inhibitor
|
chr14_-_21493910
|
0.586
|
NM_016250
NM_201535
NM_201536
NM_201537
|
NDRG2
|
NDRG family member 2
|
chr11_-_119293848
|
0.585
|
|
THY1
|
Thy-1 cell surface antigen
|
chr1_-_150947202
|
0.584
|
|
CERS2
|
ceramide synthase 2
|
chr12_-_71314247
|
0.583
|
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R
|
chr7_-_148581379
|
0.583
|
|
EZH2
|
enhancer of zeste homolog 2 (Drosophila)
|
chr18_-_25757351
|
0.577
|
NM_001792
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
chr15_+_63335086
|
0.575
|
|
TPM1
|
tropomyosin 1 (alpha)
|
chr1_-_24104743
|
0.573
|
|
LOC100506963
|
uncharacterized LOC100506963
|
chr4_-_5890142
|
0.573
|
|
CRMP1
|
collapsin response mediator protein 1
|
chrX_-_151306959
|
0.570
|
NM_001204811
NM_001011543
NM_001251828
NM_021048
|
MAGEA10-MAGEA5
MAGEA10
|
MAGEA10-MAGEA5 readthrough
melanoma antigen family A, 10
|
chr8_+_21777165
|
0.567
|
NM_015024
|
XPO7
|
exportin 7
|
chr7_-_92465929
|
0.566
|
NM_001145306
|
CDK6
|
cyclin-dependent kinase 6
|
chr15_-_83240499
|
0.562
|
NM_001079533
NM_001079534
NM_001079535
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
chr19_+_14544216
|
0.560
|
|
PKN1
|
protein kinase N1
|
chr1_-_32801606
|
0.558
|
NM_023009
|
MARCKSL1
|
MARCKS-like 1
|
chr20_+_31350190
|
0.558
|
NM_001207055
NM_001207056
NM_006892
NM_175848
NM_175849
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
chr1_+_15250578
|
0.555
|
NM_001018000
|
KAZN
|
kazrin, periplakin interacting protein
|
chr12_-_56101465
|
0.553
|
|
ITGA7
|
integrin, alpha 7
|
chr8_+_142432006
|
0.550
|
NM_007079
NM_032611
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
chr14_-_103989195
|
0.550
|
NM_001823
|
CKB
|
creatine kinase, brain
|
chr8_+_21777216
|
0.546
|
|
XPO7
|
exportin 7
|
chr10_-_76868853
|
0.545
|
NM_001007271
NM_001007272
NM_001007273
|
DUSP13
|
dual specificity phosphatase 13
|
chr20_-_62601140
|
0.545
|
NM_020713
|
ZNF512B
|
zinc finger protein 512B
|
chr6_+_160390128
|
0.544
|
NM_000876
|
IGF2R
|
insulin-like growth factor 2 receptor
|
chr16_+_202853
|
0.542
|
NM_005332
|
HBZ
|
hemoglobin, zeta
|
chr20_+_61427804
|
0.542
|
NM_018270
|
C20orf20
|
chromosome 20 open reading frame 20
|
chr7_-_752083
|
0.540
|
|
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta
|
chr1_+_39456887
|
0.540
|
NM_001136275
NM_024595
|
AKIRIN1
|
akirin 1
|
chr11_-_27494232
|
0.539
|
NM_018490
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4
|
chr5_+_92920592
|
0.538
|
|
NR2F1
NR2F2
|
nuclear receptor subfamily 2, group F, member 1
nuclear receptor subfamily 2, group F, member 2
|
chr1_+_21835841
|
0.536
|
NM_000478
NM_001127501
NM_001177520
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
chr19_+_45449228
|
0.534
|
NM_000483
|
APOC2
|
apolipoprotein C-II
|
chrX_-_153847390
|
0.531
|
NM_001327
NM_139250
|
CTAG1B
CTAG1A
|
cancer/testis antigen 1B
cancer/testis antigen 1A
|
chr5_-_77590466
|
0.527
|
|
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit
|
chr17_-_74707066
|
0.527
|
|
MXRA7
|
matrix-remodelling associated 7
|
chr21_+_44073650
|
0.523
|
NM_001001567
NM_001001568
NM_001001569
NM_001001570
NM_001001571
NM_001001572
NM_001001573
NM_001001574
NM_001001575
NM_001001576
NM_001001577
NM_001001578
NM_001001579
NM_001001580
NM_001001581
NM_001001582
NM_001001583
NM_001001584
NM_001001585
NM_002606
|
PDE9A
|
phosphodiesterase 9A
|
chr14_-_21493122
|
0.523
|
NM_201538
NM_201539
NM_201540
NM_201541
|
NDRG2
|
NDRG family member 2
|
chr1_-_150947305
|
0.523
|
|
CERS2
|
ceramide synthase 2
|
chr18_-_25756946
|
0.523
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
chr6_-_2971981
|
0.522
|
|
SERPINB6
|
serpin peptidase inhibitor, clade B (ovalbumin), member 6
|
chr17_-_74707000
|
0.518
|
NM_001008528
NM_001008529
NM_198530
|
MXRA7
|
matrix-remodelling associated 7
|
chr19_-_6720585
|
0.514
|
NM_000064
|
C3
|
complement component 3
|
chr10_+_22610138
|
0.514
|
NM_005180
|
BMI1
|
BMI1 polycomb ring finger oncogene
|
chr2_-_158731622
|
0.513
|
NM_001105
|
ACVR1
|
activin A receptor, type I
|
chr12_-_6716475
|
0.512
|
|
CHD4
|
chromodomain helicase DNA binding protein 4
|
chr18_+_12948010
|
0.498
|
|
SEH1L
|
SEH1-like (S. cerevisiae)
|
chr4_-_100009851
|
0.493
|
|
ADH5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
chr11_+_46402333
|
0.490
|
NM_001012334
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
chr20_-_47804903
|
0.490
|
NM_001037328
NM_004602
NM_017452
NM_017453
NM_017454
|
STAU1
|
staufen, RNA binding protein, homolog 1 (Drosophila)
|
chr19_+_45349584
|
0.489
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
chr4_-_100009912
|
0.489
|
NM_000671
|
ADH5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
chr1_+_11333244
|
0.483
|
NM_013319
|
UBIAD1
|
UbiA prenyltransferase domain containing 1
|
chr14_+_29236171
|
0.481
|
NM_005249
|
FOXG1
|
forkhead box G1
|
chr19_-_49944613
|
0.481
|
NM_020309
|
SLC17A7
|
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7
|
chr3_+_8775485
|
0.478
|
NM_001234
NM_033337
|
CAV3
|
caveolin 3
|
chr12_-_6716550
|
0.476
|
NM_001273
|
CHD4
|
chromodomain helicase DNA binding protein 4
|
chr6_-_2971787
|
0.474
|
|
SERPINB6
|
serpin peptidase inhibitor, clade B (ovalbumin), member 6
|
chr14_-_103989112
|
0.474
|
|
CKB
|
creatine kinase, brain
|
chr8_-_145638929
|
0.468
|
|
SLC39A4
|
solute carrier family 39 (zinc transporter), member 4
|
chr2_-_145277568
|
0.467
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
chr19_-_46285645
|
0.467
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
chr7_+_66093854
|
0.465
|
NM_001167961
NM_153033
|
KCTD7
|
potassium channel tetramerisation domain containing 7
|
chr4_+_123747815
|
0.464
|
NM_002006
|
FGF2
|
fibroblast growth factor 2 (basic)
|
chr16_+_2039945
|
0.464
|
NM_004209
|
SYNGR3
|
synaptogyrin 3
|
chr2_-_219134795
|
0.461
|
|
AAMP
|
angio-associated, migratory cell protein
|
chr3_-_50349811
|
0.460
|
NM_153281
|
HYAL1
|
hyaluronoglucosaminidase 1
|
chrX_+_9432980
|
0.460
|
NM_005647
|
TBL1X
|
transducin (beta)-like 1X-linked
|
chr22_+_45064323
|
0.459
|
NM_001017528
NM_001017529
|
PRR5
|
proline rich 5 (renal)
|
chr2_+_5832778
|
0.457
|
NM_003108
|
SOX11
|
SRY (sex determining region Y)-box 11
|
chr2_+_26467787
|
0.456
|
|
HADHB
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit
|
chr20_+_34680569
|
0.456
|
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1
|
chr2_-_158732341
|
0.453
|
NM_001111067
|
ACVR1
|
activin A receptor, type I
|
chr2_+_102508377
|
0.453
|
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
chr6_+_32121228
|
0.453
|
NM_138717
|
PPT2
|
palmitoyl-protein thioesterase 2
|
chr10_+_21823093
|
0.453
|
NM_001195627
NM_001195628
NM_001195630
NM_004641
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
chr2_-_219134865
|
0.449
|
NM_001087
|
AAMP
|
angio-associated, migratory cell protein
|
chr5_+_612404
|
0.446
|
NM_018140
|
CEP72
|
centrosomal protein 72kDa
|
chr10_+_21823573
|
0.445
|
NM_001195626
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
chr16_-_30798206
|
0.445
|
NM_001080417
|
ZNF629
|
zinc finger protein 629
|
chr7_-_148581359
|
0.445
|
|
EZH2
|
enhancer of zeste homolog 2 (Drosophila)
|
chr11_-_8739398
|
0.444
|
|
ST5
|
suppression of tumorigenicity 5
|
chr15_-_35087748
|
0.442
|
NM_005159
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
chr19_+_35629727
|
0.441
|
NM_021902
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
chr6_+_30312899
|
0.440
|
NM_001199120
NM_001199121
NM_024839
|
RPP21
|
ribonuclease P/MRP 21kDa subunit
|
chr2_-_145277879
|
0.438
|
NM_001171653
NM_014795
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
chr2_-_148779172
|
0.437
|
NM_181742
|
ORC4
|
origin recognition complex, subunit 4
|